Contineum Therapeutics (Nasdaq: CTNM) is a clinical-stage biopharmaceutical company pioneering novel, oral small molecule therapies for NI&I indications with significant unmet need. Contineum is advancing a pipeline of internally-developed programs with multiple drug candidates now in clinical tria...
Use this information to figure out if this company is an ideal customer for you.
(503) 679-xxxx
10578 Science Center Drive
San Diego, 92121
The most common Contineum Therapeutics email format is [f][last] (ex. jdoe@contineum-tx.com), currently being used by 99% of Contineum Therapeutics business email addresses. There are 9 email formats used by Contineum Therapeutics.
Contineum Therapeutics's CEO is Gail Wardlow
Contineum Therapeutics's CMO is Stephen L Huhn
Contineum Therapeutics's CFO is Peter Slover
Contineum Therapeutics's HQ is located at 10578 Science Center Drive, San Diego
Contineum Therapeutics's phone number is (503) 679-xxxx
Contineum Therapeutics's official website is contineum-tx.com
Contineum Therapeutics's revenue is $5M - $20M
Contineum Therapeutics has 51 - 200 employees
Contineum Therapeutics is in the industry of: Pharmaceuticals